InsidersTradesSigma
Track the Clearmind Medicine Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.5m. The latest transaction was disclosed on 18 June 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Clearmind Medicine Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para trastornos de salud mental. Se especializa en el uso de medicina psicodélica para mejorar el bienestar mental.